Characteristics | uOR | 95% CI | aOR | 95% CI | p value* |
---|---|---|---|---|---|
Pre-existing chronic conditions | Ìý | Ìý | Ìý | Ìý | Ìý |
 chronic lung disease | 2.48 | (1.52, 4.03) | 1.98 | (1.17, 3.34) | 0.011 |
 sleep apnea | 1.38 | (1.08, 1.76) | 1.04 | (0.79, 1.37) | 0.768 |
 a²õ³Ù³ó³¾²¹ | 1.46 | (1.15, 1.84) | 1.13 | (0.89, 1.43) | 0.310 |
 chronic heart disease | 1.26 | (0.88, 1.80) | 0.87 | (0.57, 1.32) | 0.503 |
 d¾±²¹²ú±ð³Ù±ð²õ | 0.98 | (0.72, 1.33) | 0.79 | (0.57, 1.11) | 0.177 |
 chronic kidney disease | 1.29 | (0.76, 2.19) | 1.09 | (0.58, 2.07) | 0.782 |
 high blood pressure | 1.3 | (1.09, 1.56) | 1.24 | (1.02, 1.52) | 0.033 |
 chronic blood disorder | 1.54 | (0.72, 3.28) | 0.96 | (0.40, 2.33) | 0.929 |
 o²õ³Ù±ð´Ç±è´Ç°ù´Ç²õ¾±²õ | 1.08 | (0.67, 1.73) | 0.63 | (0.40, 1.00) | 0.050 |
 back problems | 1.48 | (1.19, 1.83) | 1.05 | (0.82, 1.35) | 0.715 |
 urinary incontinence | 1.24 | (0.84, 1.81) | 0.94 | (0.63, 1.39) | 0.750 |
 bowel disorder | 1.45 | (1.06, 2.00) | 0.92 | (0.66, 1.29) | 0.642 |
 weakened immune system | 2.34 | (1.66, 3.31) | 1.71 | (1.20, 2.44) | 0.003 |
 chronic neurological disorder | 1.17 | (0.68, 2.02) | 0.72 | (0.41, 1.26) | 0.245 |
 chronic fatigue syndrome or fibromyalgia | 3.75 | (2.20, 6.40) | 2.11 | (1.19, 3.75) | 0.010 |
 s³Ù°ù´Ç°ì±ð | 0.96 | (0.49, 1.85) | 0.66 | (0.33, 1.31) | 0.232 |
 mental health condition | 1.68 | (1.37, 2.07) | 1.32 | (1.05, 1.66) | 0.019 |
 a°ù³Ù³ó°ù¾±³Ù¾±²õ | 1.54 | (1.28, 1.86) | 1.11 | (0.87, 1.42) | 0.396 |
Age at infection (ref = 15–34) | - | - | - | - | &±ô³Ù; 0.001 |
 35–49 | 0.99 | (0.86, 1.15) | 0.93 | (0.80, 1.08) | 0.331 |
 50–64 | 1.05 | (0.89, 1.23) | 0.90 | (0.75, 1.08) | 0.265 |
 65+ | 0.76 | (0.64, 0.91) | 0.59 | (0.47, 0.74) | &±ô³Ù; 0.001 |
Sex (ref = male) | - | - | - | - | - |
 f±ð³¾²¹±ô±ð | 1.35 | (1.19, 1.52) | Interaction | - | - |
Remoteness index (ref = easily accessible area) | - | - | - | - | 0.004 |
 accessible area | 0.90 | (0.78, 1.03) | 0.99 | (0.85, 1.15) | 0.843 |
 less accessible area | 1.05 | (0.83, 1.34) | 1.28 | (0.99, 1.67) | 0.064 |
 remote or very remote areas | 0.26 | (0.12, 0.54) | 0.31 | (0.13, 0.74) | 0.008 |
 u²Ô°ì²Ô´Ç·É²Ô | 0.53 | (0.28, 0.99) | 0.47 | (0.24, 0.91) | 0.026 |
Ethno-cultural composition (ref = first quintile)a | - | - | - | - | &±ô³Ù; 0.001 |
 s±ð³¦´Ç²Ô»å | 1.35 | (1.11, 1.63) | 1.34 | (1.09, 1.64) | 0.005 |
 t³ó¾±°ù»å | 1.28 | (1.08, 1.53) | 1.34 | (1.10, 1.63) | 0.003 |
 f´Ç³Ü°ù³Ù³ó | 1.53 | (1.28, 1.83) | 1.60 | (1.31, 1.96) | &±ô³Ù; 0.001 |
 fifth (highest) | 1.46 | (1.19, 1.80) | 1.58 | (1.26, 1.98) | &±ô³Ù; 0.001 |
 u²Ô°ì²Ô´Ç·É²Ô | 1.49 | (1.18, 1.89) | 1.55 | (1.15, 2.09) | 0.004 |
Situational vulnerability (ref = first quintile)b | - | - | - | - | 0.007 |
 s±ð³¦´Ç²Ô»å | 0.93 | (0.77, 1.12) | 0.97 | (0.80, 1.18) | 0.760 |
 t³ó¾±°ù»å | 0.98 | (0.82, 1.18) | 0.95 | (0.78, 1.15) | 0.599 |
 f´Ç³Ü°ù³Ù³ó | 1.14 | (0.94, 1.38) | 1.07 | (0.87, 1.31) | 0.540 |
 fifth (highest) | 0.75 | (0.61, 0.93) | 0.69 | (0.55, 0.87) | 0.002 |
 u²Ô°ì²Ô´Ç·É²Ôc | 1.08 | (0.86, 1.36) | - | - | - |
Body mass index (BMI) (ref = underweight and normal weight (BMI < 25Ìýkg/m2)) | - | - | - | - | - |
 o±¹±ð°ù·É±ð¾±²µ³ó³Ù (25Ìýkg/m2 < = BMI < 30Ìýkg/m2) | 1.07 | (0.92, 1.24) | Interaction | - | - |
 o²ú±ð²õ±ð (BMI > = 30Ìýkg/m2) | 1.38 | (1.18, 1.61) | Interaction | - | - |
 u²Ô°ì²Ô´Ç·É²Ô | 1.36 | (0.85, 2.20) | Interaction | - | - |
Pre-existing chronic health symptoms | Ìý | Ìý | Ìý | Ìý | Ìý |
 loss of appetite | 3.51 | (1.90, 6.47) | 2.03 | (1.07, 3.85) | 0.030 |
 s·É±ð±ô±ô¾±²Ô²µ | 3.21 | (2.13, 4.84) | 1.85 | (1.23, 2.79) | 0.003 |
 s²¹»å²Ô±ð²õ²õ/±è±ð²õ²õ¾±³¾¾±²õ³¾/³ó´Ç±è±ð±ô±ð²õ²õ²Ô±ð²õ²õ/»å±ð±è°ù±ð²õ²õ¾±´Ç²Ô | 1.44 | (1.13, 1.83) | 0.71 | (0.53, 0.95) | 0.021 |
Number of pre-existing chronic health symptoms (ref = 0) | - | - | - | - | &±ô³Ù; 0.001 |
 1 or 2 | 1.34 | (1.16, 1.55) | 1.32 | (1.14, 1.53) | &±ô³Ù; 0.001 |
 3 | 1.78 | (1.42, 2.22) | 1.83 | (1.44, 2.33) | &±ô³Ù; 0.001 |
 &²µ³Ù; 3 | 2.29 | (1.93, 2.72) | 1.99 | (1.59, 2.50) | &±ô³Ù; 0.001 |
Time period of first infection (ref = pre-omicron) | - | - | - | - | 0.002 |
 Omicron (December 1, 2021 – date of electronic questionnaire completion) | 0.72 | (0.60, 0.87) | 0.70 | (0.58, 0.86) | 0.001 |
 u²Ô°ì²Ô´Ç·É²Ô | 0.77 | (0.18, 3.30) | 1.03 | (0.20, 5.20) | 0.972 |
Household member testing positive for SARS-CoV-2 infection (ref = no) | - | - | - | - | 0.038 |
 y±ð²õ | 0.92 | (0.80, 1.05) | 0.94 | (0.81, 1.09) | 0.398 |
 u²Ô°ì²Ô´Ç·É²Ô | 2.09 | (0.95, 4.58) | 2.22 | (1.08, 4.53) | 0.029 |
Interaction between sex and BMI | - | - | - | - | 0.017 |
 male (ref = underweight or normal weight) | - | - | - | - | - |
 o±¹±ð°ù·É±ð¾±²µ³ó³Ù | - | - | 1.36 | (1.06, 1.75) | 0.014 |
 o²ú±ð²õ±ð | - | - | 1.79 | (1.36, 2.36) | &±ô³Ù; 0.001 |
 u²Ô°ì²Ô´Ç·É²Ô | Ìý | Ìý | 1.62 | (0.06, 42.38) | 0.772 |
 f±ð³¾²¹±ô±ð (ref = underweight or normal weight) | - | - | - | - | - |
 o±¹±ð°ù·É±ð¾±²µ³ó³Ù | - | - | 1.03 | (0.84, 1.27) | 0.758 |
 o²ú±ð²õ±ð | - | - | 1.05 | (0.85, 1.28) | 0.670 |
 u²Ô°ì²Ô´Ç·É²Ô | Ìý | Ìý | 1.05 | (0.66, 1.69) | 0.834 |
 f±ð³¾²¹±ô±ð underweight or normal weight (ref = male underweight or normal weight) | - | - | 1.64 | (1.29, 2.10) | &±ô³Ù; 0.001 |
 f±ð³¾²¹±ô±ð overweight (ref = male overweight) | - | - | 1.24 | (1.01, 1.54) | 0.045 |
 f±ð³¾²¹±ô±ð obese (ref = male obese) | - | - | 0.96 | (0.75, 1.22) | 0.717 |
 f±ð³¾²¹±ô±ð unknown (ref = male unknown) | - | - | 1.07 | (0.04, 27.51) | 0.969 |